Search Login Register

Dacarbazine (DIC) Summary

Description: An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564)

Also Known As: DIC; DTIC; ICDT; DTIC-Dome; 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide Show All >>

Networked: 5596 relevant articles (371 outcomes, 706 trials/studies) for this Drug

Key Diseases for which Dacarbazine is Relevant

  1. Melanoma (Melanoma, Malignant) : 109 outcomes 268 studies in 816 results
  2. Disseminated Intravascular Coagulation : 50 outcomes 141 studies in 2612 results
  3. Sepsis (Septicemia) : 36 outcomes 46 studies in 471 results
  4. Neoplasms (Cancer) : 32 outcomes 47 studies in 490 results
  5. Hodgkin Disease (Hodgkin's Disease) : 31 outcomes 46 studies in 229 results
Show All >>

Drugs Related to Dacarbazine

  1. Dacarbazine (DIC)
  2. Doxorubicin (Adriamycin)
  3. Vinblastine (Vinblastine Sulfate)
  4. Bleomycin (Blenoxane)
  5. Vincristine (Oncovin)
  6. Cyclophosphamide (Cytoxan)
  7. Cisplatin (Platino)
  8. Interleukin-2 (IL2)
  9. Heparin (Liquaemin)
  10. Thrombomodulin
Show All >>

Therapies Related to Dacarbazine

  1. Drug Therapy (Chemotherapy)
  2. Combination Drug Therapy (Combination Chemotherapy)
  3. Radiotherapy
  4. Aftercare (After-Treatment)
  5. Immunotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.